Neurocrine Biosciences | NBIX - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.03 1 2026-03
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
ALKERMES 135.81 96.48 2026-06
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 19.84 5.47 2026-03
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 15.28 3.96 2026-03
Exelixis 13.91 588.4 2026-03
Gilead Sciences 17.7 2.07 2026-03
Halozyme Therapeutics 11.35 11.8 2026-03
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Neurocrine Biosciences 22.1 5.99 2026-06
Pfizer 9.32 5.16 2026-03
Prothena 22.11 11.37 2022-03
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Repligen 105.09 4.39 2026-06
Rigel Pharmaceuticals 8.61 8.4 2025-03
Sarepta Therapeutics 27.27 0 2025-12
Teva Pharmaceutical Industries 24.6 14.53 2026-06
Vertex Pharmaceuticals 25.82 0.33 2026-03